4.0
Oct 18, 2013
Anonymous employee
Former employee, more than 10 years
Mumbai
Recommend
CEO approval
Business Outlook
Pros
Represented in most categories of Health care products. The sequential merger - bringing in the molecules not present earlier. Futuristic with Genetics based Medicine research. Strong in Vaccines, Respiratory Infections and conditions and Specific Life style products particularly CNS and diabetes.
Cons
Bit slow in coming out with new molecules. In the indian context - not many research molecules being introduced due to Govt bariers and price controls. No uniqueness left out as many Indian companies having already launced the research molucles. Conservative management policies, Too many cash cows and lesser Stars.
